Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)

SHA:688443 Statistics

Total Valuation

SHA:688443 has a market cap or net worth of CNY 11.44 billion. The enterprise value is 10.49 billion.

Market Cap	11.44B
Enterprise Value	10.49B

Important Dates

The last earnings date was Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688443 has 366.68 million shares outstanding. The number of shares has decreased by -0.37% in one year.

Current Share Class	366.68M
Shares Outstanding	366.68M
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-1.80%
Owned by Insiders (%)	5.67%
Owned by Institutions (%)	13.22%
Float	114.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.18
PB Ratio	7.97
P/TBV Ratio	8.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.58
EV / Sales	37.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.93

Financial Position

The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.83.

Current Ratio	4.78
Quick Ratio	4.35
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	-2.39
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.85% and return on invested capital (ROIC) is -12.82%.

Return on Equity (ROE)	-32.85%
Return on Assets (ROA)	-11.73%
Return on Invested Capital (ROIC)	-12.82%
Return on Capital Employed (ROCE)	-23.01%
Weighted Average Cost of Capital (WACC)	7.44%
Revenue Per Employee	373,913
Profits Per Employee	-759,529
Employee Count	793
Asset Turnover	0.09
Inventory Turnover	0.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.99% in the last 52 weeks. The beta is 0.72, so SHA:688443's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+7.99%
50-Day Moving Average	28.24
200-Day Moving Average	29.85
Relative Strength Index (RSI)	58.61
Average Volume (20 Days)	4,817,326

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688443 had revenue of CNY 277.82 million and -564.33 million in losses. Loss per share was -1.54.

Revenue	277.82M
Gross Profit	256.32M
Operating Income	-569.51M
Pretax Income	-564.33M
Net Income	-564.33M
EBITDA	-508.90M
EBIT	-569.51M
Loss Per Share	-1.54

Balance Sheet

The company has 2.15 billion in cash and 1.20 billion in debt, with a net cash position of 954.84 million or 2.60 per share.

Cash & Cash Equivalents	2.15B
Total Debt	1.20B
Net Cash	954.84M
Net Cash Per Share	2.60
Equity (Book Value)	1.44B
Book Value Per Share	3.94
Working Capital	1.91B

Cash Flow

In the last 12 months, operating cash flow was -392.62 million and capital expenditures -108.39 million, giving a free cash flow of -501.02 million.

Operating Cash Flow	-392.62M
Capital Expenditures	-108.39M
Depreciation & Amortization	60.62M
Net Borrowing	282.38M
Free Cash Flow	-501.02M
FCF Per Share	-1.37

Margins

Gross margin is 92.26%, with operating and profit margins of -205.00% and -203.13%.

Gross Margin	92.26%
Operating Margin	-205.00%
Pretax Margin	-203.13%
Profit Margin	-203.13%
EBITDA Margin	-183.18%
EBIT Margin	-205.00%
FCF Margin	n/a

Dividends & Yields

SHA:688443 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.37%
Shareholder Yield	0.37%
Earnings Yield	-4.93%
FCF Yield	-4.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3